ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%


PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Estradiol Gel, 0.06%. ANI’s Estradiol Gel, 0.06% is the generic version of the reference listed drug (RLD) EstroGel® Gel, 0.06%.

See the rest here:
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

Related Posts